Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2014-09-14 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Reinstatement to Official Quotation 1 page 78.3KB
Regulatory Filings Classification · 95% confidence The document is a short market release announcing the reinstatement of trading following suspension, mentioning restructuring plans and funding finalization. It is an official notice related to stock exchange listing status, not a detailed financial report or other specific filings. The length is only 470 characters, indicating it is an announcement rather than a full report. This fits the category of Regulatory Filings (RNS) as a general regulatory announcement about compliance and listing status.
2014-09-14 English
Suspension from Official Quotation 2 pages 328.2KB
Regulatory Filings Classification · 95% confidence The document is a market release announcing the immediate suspension of the company's securities from official quotation at the company's request. It is a regulatory announcement related to trading status rather than a financial report or detailed filing. The document is very short (451 characters) and does not contain financial data or detailed report content. It fits best under Regulatory Filings (RNS) as a general regulatory announcement about trading suspension.
2014-09-10 English
Trading Halt 2 pages 318.9KB
Regulatory Filings Classification · 95% confidence The document is a market release announcing a trading halt for Genetic Technologies Limited pending a future announcement. It does not contain financial data, report content, or detailed information about company performance or governance. The document is short (672 characters) and serves as a regulatory announcement about trading status rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2014-09-08 English
Nasdaq deficiency notice 2 pages 127.5KB
Regulatory Filings Classification · 95% confidence The document is an announcement dated 3 September 2014 from Genetic Technologies Limited regarding receipt of a Nasdaq deficiency notice due to the company's share price falling below the minimum required bid price for continued listing on Nasdaq. It explains the compliance period and potential consequences if the company does not regain compliance. The document is a regulatory announcement about the company's listing status and does not contain financial statements, management discussion, or detailed report data. It is not a full report but a compliance notification related to listing rules. The document length is 4453 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit other specific categories like Delisting Announcement (DLST) since the delisting is not yet confirmed but only a deficiency notice has been received.
2014-09-02 English
ASX Appendix 4E - 30 June 2014 35 pages 2.4MB
Regulatory Filings
2014-08-28 English
Notice of EGM and sample form of proxy 16 pages 1.8MB
Regulatory Filings
2014-08-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.